You just read:

Prime Therapeutics Study Finds a Diabetes Drugs Value Based Insurance Design Improves Adherence, Doesn't Lower Total Cost of Care

News provided by

Prime Therapeutics LLC

Oct 13, 2017, 11:30 ET